Ampullary carcinoma
Clinical trials for Ampullary carcinoma explained in plain language.
Never miss a new study
Get alerted when new Ampullary carcinoma trials appear
Sign up with your email to follow new studies for Ampullary carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a smaller incision offer the same cancer surgery outcome?
Disease control Recruiting nowThis trial compares two surgical techniques for removing tumors near the pancreas (non-pancreatic periampullary adenocarcinomas). One method uses a single small incision plus one extra port, while the other uses the conventional five-port approach. The study will enroll 232 adult…
Matched conditions: AMPULLARY CARCINOMA
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New combo pill aims to extend life in tough bile duct cancer
Disease control Recruiting nowThis study tests whether adding an experimental drug (D07001) to standard chemotherapy (capecitabine) helps people with advanced bile duct cancer live longer. About 195 adults whose cancer has not responded to earlier treatments will receive either D07001 or a placebo, plus capec…
Matched conditions: AMPULLARY CARCINOMA
Phase 3 • Sponsor: InnoPharmax Inc. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Keyhole surgery vs. open surgery for pancreatic cancer: which is safer?
Disease control Recruiting nowThis study compares two types of Whipple surgery for people with pancreatic or nearby cancers: the traditional open surgery and a newer keyhole (laparoscopic) approach. About 90 adults with resectable tumors will be randomly assigned to one of the two procedures. The goal is to s…
Matched conditions: AMPULLARY CARCINOMA
Sponsor: Minia University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Genetic cheat code may unlock safer, stronger chemo cocktail for tough cancers
Disease control Recruiting nowThis early-stage trial is testing a powerful mix of five chemotherapy drugs for people with advanced upper gastrointestinal cancers, including pancreatic and stomach cancers. The study uses each person's genetic profile to adjust the dose of one of the drugs (irinotecan) to try t…
Matched conditions: AMPULLARY CARCINOMA
Phase 1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC